Abstract
Pregnancy-associated breast cancer (PABC) is the most common malignancy diagnosed in women of childbearing age and is increasing in frequency as the average age of pregnancy rises. Outcomes for PABC are similar to age- and stage-matched controls. In this review, we discuss current treatment recommendations for PABC. Treatment of PABC involves complex coordination by a multi-disciplinary team of providers including surgical, radiation, and medical specialists. The timing and administration of these therapies must be tailored to account for the pregnancy in order to keep both woman and fetus safe. Additional data is needed on the safety of newer breast cancer therapies during pregnancy. With close oversight, breast cancer therapy can be delivered effectively for the patient and safely for the developing fetus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
